Hi Stormer, You might recall that when Management started the...

Hi Stormer,

You might recall that when Management started the Entitlement process that i said I would be standing side by side with you, pitch fork in hand, if management was unable to raise the shortfall of the $5.5 million within the 3 months that they said they would?

And in mid Feb, just 3 weeks into that 3 month period, you said:

"haha NZ

Why do you believe the climb up should start this week when they have not managed to generate any interest in DXB for months? ( and still can't judging by the non placement of the shortfall)"

Well the pitch fork never came out as they easily raised the shortfall, and an extra $2.5 million to boot, well within time, and by the sounds of it they actually had to turn some money away.

I'm not sure raising 37% more funds than originally budgeted deserves a "fail". Far from it.

Yep some of those cheap shares are now being sold which is holding back the share price, for now. However there has been good volume traded (ie interest) over the last couple of weeks and importantly, as has been mentioned many times, DXB can now focus on the science. It's that science that will bring the results that everyone wants (both health and financial).

We just have to let them do their thing. If the science is good, Phase 2B results will give the share price the boost you (and everyone else) is after.

Cheers
Pies